At a glance 9 picks (Subscribing 1, Filings & hearings 4, Debut 4). Headline: Beijing Sinotau International Pharmaceutical Technology Co., Ltd. (09941).
This week's picks: 9 items FinKit IPO Snapshot · 00:00 New Score 100 Biotech firm Sinotau is now taking subscriptions at HK$52.00-68.00, closing 19 November and listing 24 November, with grey-market trading on 23 November; it focuses on radiopharmaceutical diagnostics and therapies.
Why this: Published within 6 hours · Relevant to this topic
FinKit IPO Snapshot · 15:03 New Score 80 Biotech firm Hemay has published an offer range of HK$15.50-18.90, but its listing date has been delayed and the outcome is still pending.
Why this: Published within 6 hours · Relevant to this topic
FinKit IPO Snapshot · 15:03 New Score 80 Robotics company Microintelligence has published an offer range of HK$16.63-21.46, with the listing date still to be set.
Why this: Published within 6 hours · Relevant to this topic
FinKit IPO Snapshot · 15:03 New Score 80 Tourism company Slender West Lake has published an offer range of HK$3.92-5.07, with the listing date still to be set.
Why this: Published within 6 hours · Relevant to this topic
FinKit IPO Snapshot · 15:03 New Score 80 Logistics firm Yongkang Holdings has published an offer price of HK$2.44, with the listing date still to be set.
Why this: Published within 6 hours · Relevant to this topic
FinKit IPO Snapshot · 00:00 Score 65 Commercial space company Adaspace listed on 13 November at an offer range of HK$24.90-33.20, working on satellites and space applications.
Why this: Relevant to this topic
FinKit IPO Snapshot · 00:00 Score 65 Robotics chipmaker Amicro listed on 12 November at an offer range of HK$9.27-11.58.
Why this: Relevant to this topic
FinKit IPO Snapshot · 00:00 Score 65 Semiconductor firm HOSIN listed on 12 November at an offer range of HK$72.29-82.90.
Why this: Relevant to this topic
FinKit IPO Snapshot · 00:00 Score 65 Traditional Chinese medicine company Neautus listed on 11 November at an offer range of HK$40.20-50.55.
Why this: Relevant to this topic